Clinical Trial Update: Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB

View source ↗

Summary

A completed clinical trial update reporting longer-term recurrence rates in bladder cancer patients following Hexvix (Cysview) fluorescence cystoscopy with TURB…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Hexvix (hexaminolevulinate hydrochloride)

Snippet

Sponsor: Photocure | Conditions: Bladder Cancer | Status: COMPLETED | Results posted: 2013-11-14